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Abstract
Background: In Ghana, there is extensive over-the-counter dispensing of antibiotics, resulting in high levels of
inappropriate use, and an increase in antibiotic resistance. Regulations prevent Licenced Chemical Sellers (LCS,
Over-the-Counter Medicine Sellers) from selling antibiotics other than Cotrimoxazole. In practice, however, these
sellers sell a variety of antibiotics. This paper aims to provide insight into the differences between regulatory and
community demands on the sale of antibiotics, and to explore how these differences in demand could be resolved
to facilitate safe and appropriate use of antibiotics in rural Ghana.
Methods: A total of 32 in-depth interviews were conducted in the Kintampo North and South Districts in Ghana;
16 among antibiotic suppliers, predominantly LCS, and 16 among community members. Six focus group discussions
were also conducted among 40 community members. Data were coded using Nvivo 10 and thematically analyzed in
line with study objectives. The results are presented as narratives with quotes to illustrate the findings.
Results: Generally, antibiotic suppliers were aware that regulations prevent LCS from selling antibiotics except
Cotrimoxazole. However, LCS sell all types of antibiotics because of community demand, economic motivations
of LCS, and the poor implementation of regulations that are intended to prevent them from selling these
medications. Factors that influence community demand for antibiotics include previous knowledge of effectiveness of
some antibiotics, delays in seeking care at health facilities, financial constraints, and distance to health facilities. LCS
suggested that they should be trained and allowed to sell some types of antibiotics instead of being prevented
completely from selling. Community members also suggested that Community-based Health Planning and Services
(CHPS) compounds should be equipped to dispense antibiotics.
Conclusion: The sale of antibiotics by LCS at the community level is influenced by both structural and individual
contextual factors. There is a need to educate community members on the appropriate access and use of antibiotics in
rural Ghana. In addition, rather than enforcing rules that go against practice, it may be more effective to regulate the
sale of antibiotics by LCS and train them to make their dispensing more appropriate. CHPS compound could also be
equipped to dispense some antibiotics to improve appropriate antibiotic access at the community level.
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Background
Inappropriate use of antibiotics is a major public health
challenge in many Low and Middle Income Countries
(LMIC) [1, 2]. In LMICs, there is extensive “over the
counter” sale of antibiotics from unlicensed suppliers,
resulting in high levels of inappropriate use and a conse-
quent increase in antibiotic resistance (ABR) [3]. This is
leading to the loss of many first line antibiotics as effect-
ive treatments [4].
One of the major drivers of ABR in LMICs is the exist-
ence of plural health systems, whereby both government
and private institutions provide health services [5].
Although the existence of multiple healthcare providers
increases access to healthcare, there is also a variety of
private providers with various degrees of knowledge and
approaches to clinical practice, and many of whom are
unapproved [6]. As a consequence, people often obtain
antibiotics from unauthorized private providers [5].
These sellers may have insufficient training, understand-
ing, and skills, as well as a range of different relation-
ships with formal regulatory systems. At the same time,
they are also influenced by financial incentives to sell
antibiotics and to comply with customer demands and
expectations rather than the law [7].
In Ghana, according to the Health Professions Regula-
tory Body Act, 2013 (Act 857), only medical doctors,
physician assistants, midwives and nurses trained in pre-
scribing are eligible to prescribe registered antibiotics
[8]. Moreover, the Pharmacy Act, 1994 (Act 489) in-
cludes relevant sections on the dispensing and sale of
medicines, including antibiotics. According to section 31
of the Act, ‘no person shall do a business of supplying
from any premises restricted drugs classified by regula-
tions as class A drugs/prescription only medicines, class
B drugs/pharmacy only medicines or class C drugs/over
the counter medicines, unless that person has a valid
general or limited license’ [9]. About 80% of medicine
outlets in rural communities in Ghana are Licenced
Chemical Sellers (LCS, over-the-counter medicine
sellers), who are mostly the first point of contact for
healthcare [10]. Section 29 of the Pharmacy Act, expli-
citly prevents these LCS from selling class A and B med-
icines including antibiotics [9], except for oral
Cotrimoxazole which is usually in suspension and com-
monly dispensed for the treatment of infective diarrhea,
urinary tract infections and upper respiratory tract infec-
tions [11].
In line with these regulations, pharmacies are allowed to
dispense Amoxicillin, Flucloxacillin, Norfloxacin + Tinida-
zole, Ciprofloxacin, Doxycycline, Tetracycline, Erythro-
mycin and Ampicillin based on the recommendation of a
practicing pharmacist [8, 12]. However, beyond the autho-
rized antibiotics, pharmacies and LCS frequently dispense
other antibiotics with or without prescription. To secure, in
the public interest, the highest standards in pharmacy prac-
tice, a regulatory body - the Ghana Pharmacy Council -
was established, but it has inadequate resources to fulfil its
mandate [13].
Considering the influence of regulation and community
(including LCS and community members) demand on ac-
cess to antibiotics, interventions aimed at addressing the
accessibility challenge need to consider synthesizing the re-
lationships between regulatory structures and the commu-
nity [6, 14]. Interventions including regulations that take
into account the demands of the community are more
likely to be successful [14, 15]. This paper aims to provide
insight into the differences between regulatory and commu-
nity demands on the sale of antibiotics, and to explore how
these differences in demand could be resolved to facilitate
safe and appropriate use of antibiotics in rural Ghana.
Theoretical perspective
This study topic, concerning the differences in demand be-
tween regulatory structures and the community on the sale
of antibiotics in Ghana, can be examined through the lens
of the theory of structuration. Structuration is a social the-
ory concerning the production and reproduction of social
systems that is based on the analysis of both social struc-
tures (social forces/institutions) and agents (individuals), but
without giving primacy to either [16–18]. It explores the ex-
tent to which, and how social forces and individuals shape
our social reality. ‘Structures’ are rules and resources that
individuals draw upon in their activities/practices and that
produce and reproduce social systems. Social structures in-
fluence, for example, the economic system, legal system,
health system, political system, and culture. ‘Agency’ refers
to the capacity of individuals to act independently of these
structures and to make their own free choices. Thus indi-
viduals have the ability to monitor and evaluate their
actions in the context within which these actions take place
[16–19].
It is important to note that the relationship between
structures and individuals is bi-directional. The
structure-agency relationship as outlined in structuration
theory implies that people ‘make’ society, but are at the
same time they are constrained by it. Consequently, struc-
tures and actions of individuals cannot be analysed separ-
ately [16].
Situating our context within structuration theory, the
antibiotic regulatory structures in Ghana (Pharmacy act,
Pharmacy council) and human agency (LCS and com-
munity members) are not mutually independent, but
rather they comprise two complementary components of
the framework that determines the sale of medicines,
including antibiotics. This theory can help us to under-
stand the intersection of practices in structural relations
and how institutionalized individual practices connect to
produce system integration.
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Methods
The methods for this study are reported according to the
consolidated criteria for reporting qualitative research
framework (COREQ) [20].
Study design
This study is part of the Antibiotic Access and Use
(ABACUS) study, which has employed a mixed methods
approach among antibiotic suppliers and community
members across six Low and Middle Income Countries
in Asia and Africa, including Ghana [21]. This paper re-
ports on factors affecting community antibiotic access
and use that prevailed in the study area that were ex-
plored through qualitative in-depth interviews and Focus
Group Discussions (FGDs).
Study area
Data were collected in the Kintampo North and South Dis-
tricts in Ghana between January and June, 2017. The two
districts are located within the forest-savannah transitional
ecological zone in the Brong-Ahafo Region. The study area
covers an area of 7162 km2 with a resident population in
2013 of approximately 151,000 [22, 23]. The study setting is
largely rural and subsistence farming is the major occupa-
tion. The majority of inhabitants in this area initiate treat-
ment for some ailments at home, then, if necessary,
continue to the LCS to buy medicines, including antibiotics.
They may finally end up in a public health facility if their ill-
nesses do not resolve [24]. Public health facilities (govern-
ment owned) in the area include two hospitals, 12 health
centres/ clinics, and 30 Community-based Health Planning
and Services (CHPS) compounds; while the privately
owned health facilities include four clinics, two maternity
homes, four pharmacies, and 86 LCS. In addition to these
formal private and public health providers, there are also
informal medicines sellers who provide health services to
urban as well as to the majority of deprived rural poor
community members in the study area.
Data collection
Issues on the differences in regulatory and community
demands on the sale of antibiotics, and on how the dif-
ferences in demand could be resolved were explored
through qualitative in-depth interviews (IDIs) and Focus
Group Discussions (FGDs). IDIs were used to collect in-
formation about individual respondents’ experiences and
opinions, while the FGDs were used to derive insights
into community norms on the topic. Antibiotic supplier
and community member IDIs and community member
FGDs were performed consecutively; themes emerging
from the IDIs were used to inform the discussions in the
FGDs.
Selection of participants
 Antibiotic suppliers IDIs
Sixteen IDIs were conducted among dispensers of an-
tibiotics including two pharmacists, two dispensing tech-
nicians, one physician assistant, one health assistant,
three community health officers, and seven LCS
(Table 1). The respondents were broadly representative
of the categories of antibiotic dispensers in the study
area: all purchase or dispensing points for antibiotics in
the study area (public or private, from public hospital
pharmacies to street vendors) had previously been iden-
tified and mapped. Antibiotic suppliers were eligible for
IDIs if they were 18 years or older and if they were dis-
pensing or selling antibiotics as observed through the
mapping exercise. The suppliers were purposively se-
lected to include similar proportions of supplier types
identified in the mapping exercise.
 Community members IDIs
Community members who were 18 years old and above
were randomly selected from the database of the Kin-
tampo Health and Demographic Surveillance for the study
area [22]. The database contains a list of all residents in
the study area. Selected community members who were
willing to speak about their experiences with and attitudes
towards medicines were interviewed. All community
members who were selected agreed to be interviewed. Six-
teen IDIs were conducted among community members
from different households. The 16 IDIs were conducted
with eight mothers who care for children five years or
younger and eight community members (two males and
two females younger than 60 years, two males and two
females of 60 years or older) (Table 1).
 Community members FGDs
Six FGDs were conducted among community mem-
bers to further discuss community norms on access to
and use of antibiotics. In the first four FGDs, community
members 18 years old and above were randomly selected
from the HDSS database to participate in this study.
Each group was made up of 6–8 community members.
The participants in the other two focus groups (female
church leaders and male primary school teachers) were
purposively selected as social groupings relevant to the
local context (Table 1).
Data collection procedures
Eligible antibiotic suppliers and community members
were informed about the purpose and procedures of the
study. The written information sheet as well as the
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informed consent criteria were read to the potential par-
ticipants. Participants who consented for the inter-
views were provided with the copies of the written
study information sheets, and signed inform consent
forms were collected before the actual interviews
were carried out. Each discussion session was audio
recorded and conducted by a moderator and a
note-taker. Community members IDIs and FGDs were
held in Twi dialect (a widely spoken local dialect) in
the compound of the participant, a church, classroom,
or under a shaded open space. Antibiotic suppliers
IDIs were conducted in Twi or English in the prem-
ises where the medicines are sold to clients at a time
when attendance was very low to avoid interruption
by potential clients. The discussions were facilitated
by a moderator using an interview guide that was
made up of predetermined questions and themes. The
main themes explored include regulatory and commu-
nity demands on the sale of antibiotics and how the
differences in demand could be resolved to improve
appropriate use of antibiotics. Other related emerging
issues were also discussed. Notes on responses and
other non-verbal communications were also taken by
a note-taker. IDIs and FGDs generally lasted for
about 30 min and one hour respectively. Interview
sessions were brought to an end when the moderator
had exhausted all questions on the interview guide
and on other emerging issues.
Data management and analyses
A thematic analytical approach was used in the man-
agement and analysis of the qualitative data. The pro-
cesses used for the analysis followed the approach
proposed by Braun and Clarke [25]. The audio re-
cordings of the interviews were transcribed into Eng-
lish verbatim by the researchers. Interviews conducted
in Twi were translated into English during transcrip-
tion. Transcripts were then checked for completeness
and accuracy by vetting them to match the audio re-
cordings, whilst we familiarized ourselves with the
data to gain a broad understanding of the content of
the interaction and whilst also taking notes of import-
ant ideas. The transcripts were imported into
NVivo10. In the NVivo, a priori themes were devel-
oped around regulatory and community demands on
the sale of antibiotics and on how the differences in
demand could be resolved to guide the coding of
transcripts. During the process, more themes and
sub-themes emerged that captured other,
inductively-derived issues. This was followed by inter-
pretive analysis of the collated codes whereby themes
were combined, refined, separated or discarded where
necessary.
Results
The Results section is made up of four sub-sections,
including (i) demographic characteristics of the respon-
dents, (ii) the regulatory demands on the sale of antibi-
otics, (iii) community demands for antibiotics, and (iv)
suggestions on how to resolve the differences in regula-
tory and community demands on the sale of antibiotics.
Results are presented as a narrative with selected quotes
to support the findings.
(i) Demographic characteristics of respondents.
A total of 72 respondents participated in the study of
whom 28 (39%) were males and 44 (61%) were females.
Sixty percent of the respondents were between the ages
of 18 to 35 years. Also, 26 (36%) of the respondents had
no formal education, and 23 (32%) were farmers.
(ii) Regulatory demands: knowledge of the regula-
tions governing the sale of antibiotics.
It was common knowledge among all categories of
suppliers that antibiotics are supposed to be dispensed
by hospitals and pharmacies according to regulations:
There are categories of facilities that can sell or
dispense antibiotics. When you come to the hospital
we can dispense antibiotics, but in the communities I
Table 1 Summary of interviews and categories of respondents
for IDIs and FGDs
Type of interview and
respondents categories
No. of respondents/
participants
Antibiotic suppliers IDIs
Pharmacists 2
Dispensing Technicians 2
Physician Assistant 1
Health Assistant 1
Community Health Officers 3
LCS 7
Community members IDI
Mothers of children ≤5 years 8
Males ≥18 and < 60 years 2
Females ≥18 and < 60 years 2
Males ≥60 years 2
Females ≥60 years 2
Community member FGDs
Females ≥18 and < 30 years old 6
Males ≥18 and < 30 years old 8
Females ≥30 years old 6
Males ≥30 years old 6
Female church leaders ≥18 years old 8
Male primary school teacher ≥18 years old 6
Total 72
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know only accredited pharmacies can sell and
dispense antibiotics. We have LCS but they are not
supposed to sell antibiotics (IDI, Pharmacist#2).
Whilst this finding was corroborated by some LCSs, it
also emerged that others are unaware that they are per-
mitted to sell cotrimoxazole.
The license I am using in this shop right now is class
C, thus for the Licenced Chemical Seller to sell pain
killers and some anti-histamines… let’s say something
like first aid. So we are only dealing with first aid for
the meantime. That is what we have been licensed to
be selling. In my case as a chemical seller, I am not
supposed to dispense any antibiotic. In no case should
I dispense any antibiotic (IDI, LCS #1).
There were definite responses on the categories of
practitioners who are approved to dispense antibiotics:
A pharmacist can dispense antibiotics, a doctor can
dispense, a dispensary technician, [but a] Licenced
Chemical Seller cannot dispense, and sometimes the
midwives. Even nurses are not allowed to dispense or
give antibiotics. Apart from these people, anybody
selling or dispensing antibiotics is illegal (IDI, LCS #1).
Generally, dispensers mentioned that antibiotics are
prescription-only medicines that are to be dispensed by
only approved and qualified practitioners.
Antibiotics are prescription-only medicines. You don’t
“use an oral means” (make a verbal request) to buy.
The dispenser must therefore be professional to under-
stand that they can be sold with prescription only
(IDI, Pharmacist#1).
By contrast, community members were generally un-
aware of any regulations governing the sale of antibi-
otics. It emerged they do not know that they are not
supposed to buy antibiotics from the LCS, except
cotrimoxazole.
We have not heard anything that if you want to buy
antibiotics, you have to see a doctor first or buy from
the Pharmacy. We think once it is in the Licenced
Chemical Seller’s shop, you can go and buy (IDI,
mother of under-five#1).
(iii) Community demands for antibiotics.
In spite of the regulations, dispensers and community
members mentioned that antibiotics can be accessed
from all types of medicine sellers and dispensers at the
community level, with or without prescription:
Yes, I can easily buy it without prescription. Especially
if I know it is good for me. Yes, recently I bought the
white antibiotics [Chloramphenicol] I told the supplier
that I needed some for my son’s sore. They did not say
anything, neither did I ask any questions (IDI with
Community members, Females 18–30 years,
respondent#1).
Most of the antibiotics we take are not prescribed by a
Doctor; we just buy and take it like that. For instance,
when someone has stomach ache, he just buys red and
yellow (tetracycline) and pours it into akpeteshi
[locally brewed gin from palm tree] and takes (FGD,
Primary school teachers respondent#5).
This finding was corroborated by suppliers:
Yes, they come to ask; for the medicines we sell here,
they come to ask for specific medicine and we give it to
them. Over here it is usually, I am buying this, I am
buying that (IDI, LCS #2).
They ask for the Amoxicillin, Ampicillin and Flagyl.
When they come they say this is what I want, they will
not explain to you that I am buying this because this
is what is happening to me. They say what they want
and you give it to them (IDI, LCS #4).
A variety of reasons were given for community mem-
bers accessing antibiotics without prescription, as ex-
plained below.
a) Previous knowledge and experience
Community members who have previously experi-
enced the effectiveness of some antibiotics tend to seek
out the same antibiotics when they are sick, or they may
recommend such antibiotics to others who may be ex-
periencing similar symptoms to their own.
Many of them ask for particular drugs, sometimes based
on recommendations from others on the effectiveness of
the drugs (IDI, Dispensing Technician #1).
We have a problem with that. Some patients come
with some packages of drugs they have used before
and ask for those drugs, even if the condition is not
related to the drug they are asking for (IDI, Physician
Assistant).
Others also come to point to what they want. They say
this is what I usually take, this is what the doctor
normally prescribes for me and it works for me
(IDI, LCS #3).
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This finding was confirmed by at least one community
member:
If you have previously used an antibiotic, you just go
and buy one from the drug store. Recently I bought
some antibiotics (Amoxicillin) because I knew what I
wanted [so] I just went to the drug store and asked for
it. (IDI, Female community member_18-60 years,
respondent #1).
b) Delays at hospital
Delays in receiving treatment at the hospital consti-
tuted a major disincentive for seeking care at the hos-
pital as well as an incentive for people to seek care at
the LCS shops and other medicine sellers. This issue
was expressed by both suppliers and community
members:
Yes, self-medication is very common and it is the fault
of the hospital. If someone goes to the hospital, they
can stay there the whole day [before they are seen by a
doctor] - that is not good. So people are reluctant to go
to the hospital for malaria and cough (IDI, Dispensing
Technician#2).
I will say something about the hospital; a lot of
people don’t like going to the hospital. What they
say is that when they visit the hospital, they will sit
there for a very long time before they attend to
them, so you may end up dying with the illness you
took to the hospital. For this reason, they will go to
the drug store because they know when they buy the
medicine it will cure their illness; so they will move
straight to the drug store to buy medicine to cure
their illness because they will waste their time when
they go the hospital
(FGD, female church leaders, respondent#8)
c) Financial challenges
Financial constraints also came up in the responses as
one of the major reasons for accessing antibiotics from
unapproved medicine providers, without prescription.
Some people go to drug stores to buy medicine
when they are sick because they think that when
they go to the hospital they can’t pay, and the
transport too is a challenge (FGD male above 30
years, respondent#4).
Related to the cost is the fact that medicines are usu-
ally prescribed in the hospital for people to go and buy
in the open market, so it is better for them to go and
buy from the drug shops where they think medicines are
relatively cheaper.
In terms of cost, some people say that when they go to
the hospital, medicines will be prescribed for them to
go and buy from the open market, so there is no need
to go to the hospital… it is better they enter the drug
stores themselves (FGD, Primary school teacher,
respondent#2).
The money you spend buying medicine from the drug
store is less than what you spend at the hospital.
(FGD, female church leaders, respondent #2)
d) Distance to health facilities
Long distances to the nearest health facility was a chal-
lenge especially when the illness is perceived to be
unserious.
Distance is another challenge because some people
stay far away from health facilities so when they
are sick it becomes a big challenge for them to
reach the facilities. (FGD male above 30 years,
respondent#3)
e) Financial gains by LCS
Dispensers in the community who are mostly LCS are
not prepared to stop selling antibiotics because of the
money they make from them, even though they know it
is against regulations. The disposition by LCS to con-
tinue the sale of antibiotic was because stopping the sale
of antibiotics will affect their business:
The other drugs do not run [get sold] fast. They just
come to buy ten pesewas, 20 pesewas (< 0.05USD)
etc. How long will it take to recover your money? But
with the antibiotic, they buy GHC 4 in Ghana
currency (0.91USD), GHC 3 (0.68USD), so even if they
buy 10 a day, you make something out of it.
(IDI, LCS #3)
f ) Weak implementation of regulations on
antibiotic sales
It also emerged that the regulation regarding the sale
of antibiotics is weakly implemented by Pharmacy Coun-
cil. LCS and drug peddlers therefore evade the regula-
tions concerning antibiotics.
The checks are not done well…. Let’s say if he
(pharmacy council person) should come here today,
the very moment he gets to town all the chemical
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sellers around will get to know the pharmacy council
person is in town and they will all hide their things
[antibiotics]. (IDI, LCS #1).
Though the regulations governing the sale of
antibiotics are sufficient, we always find a way around
it (IDI, LCS #1).
So whether they train us or not, we will sell. We will
hide to sell (IDI, LCS #3).
(iv) Suggestions on how to resolve the differences
in regulatory and community demands on the sale of
antibiotics.
Generally, dispensers mentioned that instead of pre-
venting LCS from selling antibiotics, they should rather
be trained to sell antibiotics in a proper, safe way. This is
because there is a demand for antibiotics at the commu-
nity level while there are no approved dispensers of anti-
biotics there or other good access to healthcare:
We want the doctors to train us so that we can sell to
support the community, because it is not everyone who
can go to the hospital in town. So if they train us to
know why we are not allowed to sell, then we can
know [what to do] to be able to support them. When
the malaria Rapid Diagnostic Test kit was introduced,
we were trained on how to do the test and we are able
to do that. Initially we treated all fever cases as
malaria and people continued to take the
antimalarial. (IDI, LCS #3).
To facilitate the appropriate dispensing of antibiotics
by the LCS, it was suggested that antibiotics are rather
packaged as complete doses for specific disease episode
(as opposed to current practice whereby individual pills
are placed into a small paper bag by the seller) and dis-
pensed according to treatment guidelines.
I think the antibiotics should come as complete packs,
so that lower cadres like us can also dispense. (IDI,
LCS #1).
I was trying to talk about treatment guidelines. For all
the medicine we are using, we have treatment
guidelines so if the antibiotic that you are giving is not
in that treatment guideline, I don’t think we can use
it. (IDI, Health Assistant #1).
Some community members also suggested that the gov-
ernment should equip the Community Based Health and
Planning Services (CHPS) compounds with the capacity
to dispense antibiotics. CHPS is a community-based ap-
proach for extending health services to deprived
communities through community-based service delivery
point (a ‘CHPS compound’). These are managed by Com-
munity Health Officers who provide clinical care (includ-
ing basic antibiotic prescriptions) for minor ailments as
well as preventive and health promotion services delivered
through house-to-house visits.
What I think is that, we should furnish the CHPS
compounds with the necessary equipment and
personnel as we do for the bigger hospitals. This will
be helpful so that if even the person has no money to
travel to the bigger hospital, at least they can walk to
the CHPS compound. (FGD, Males 18-30 years
respondent#8).
Discussion
This paper reports on the differences in regulatory and
community demands on the sale of antibiotics in rural
Ghana. The research was conducted in a context where
private health facilities such as Licenced Chemical
Sellers (LCS), who are not permitted to sell antibiotics,
contribute significantly to the provision of healthcare,
including through the illegal sale of these medicines.
In Ghana, a wide range of antibiotics is available on
the open market, and acquiring drugs over the counter
is a very common practice [26]. This is in spite of the
Pharmacy Act, 1994 (Act 489), which prevents LCS from
selling and dispensing Class A/prescription only medi-
cines, and B Class /pharmacy-only medicines including
antibiotics. Our findings of unregulated access to antibi-
otics without prescription reflects the results of studies
in other LMICs [1, 3]. In some higher income countries
like Spain, the practices of un-prescribed antibiotics dis-
pensing is also reported to be on the increase [27–30].
In line with the theory of structuration the findings in
our study and from others indicate that a new form of
structure regarding access and sale of antibiotics has
been created informally, to serve the needs of LCS
(or their equivalent) and community members. This
practice requires urgent attention in order to main-
tain the effectiveness of antibiotics [16, 17, 31].
The sale of antibiotics by LCS with or without prescrip-
tion is as a result of weak implementation of regulations on
antibiotic sales, along with prevailing community customer
demand for antibiotics and financial gain by LCS. As in
other studies conducted in LMICs [27], the most common
reasons given for selling antibiotics without prescription is
customer demand. Consequently, over-the-counter medi-
cine sellers stock and sell antibiotics against regulations in
order to meet the demands of their customers and to
maximize profit [27]. Customers insist on buying antibiotics
even if dispensers think that the antibiotics they are asking
for may not be right for their conditions [32]. We found
Afari-Asiedu et al. Journal of Pharmaceutical Policy and Practice           (2018) 11:30 Page 7 of 10
that some customers insist on certain antibiotics because of
previous use and knowledge of their effectiveness. This
shows that LCS and community members may be engaging
in these practices because they lack sufficient knowledge
and information to understand the risks of their behaviours
in which case public health education is key. Also compar-
able to other studies, community members’ persistent inter-
est in buying antibiotics without prescription from LCS was
the result of their being relatively cheaper than the cost
from the pharmacy or the cost of attending hospitals for
treatment [27]. It is important to recognise, however, that
access to antibiotics from LCS occurs not only because of
the weakness of the regulation on the sale of antibiotics. As
the structuration theory indicates, it is also as a result of the
fact that human agency (manifested through LCS and com-
munity members) and social structures (manifested
through regulations on antibiotics) have different demands
with regards to the sale of antibiotics.
Community members also demand and buy antibiotics
without prescription from LCS because of the delays
found in health facilities. It is therefore important to im-
prove the health system whereby waiting times are re-
duced because, as per the principle of social structure
reproduction, if individuals find it difficult to act in any
way that is expected, social forces will emerge that pro-
vide incentives to act otherwise [16, 17, 31]. For instance
delays in accessing health care in hospitals can push in-
dividuals to demand for and buy antibiotics from LCS
who are close to them in their communities and other
unapproved sellers [33]. Our findings on delays in hospi-
tals is comparable to study results from Kenya and
Sudan, where 45 and 39% of respondents respectively
said they self-medicate because of delays in hospitals
[34, 35]. Closely linked to the delay is the distance to
appropriate antibiotic sales points/dispensers. This en-
courages people in some communities to purchase anti-
biotics from LCS in the case of Ghana, without
prescription. Similar to this finding, a study in India
found that participants who had no access to a licensed
allopathic trained doctor in their own village, and who
faced significant travel costs, often made the decision to
seek care directly from unapproved dispensers in their
villages [36]. We also found that a lack of knowledge
about the approved dispensers of antibiotics by
customers is a reason for buying antibiotics without
prescription. This is because customers perceive dis-
pensers in the community as professionals, and they
trust them [4].
The overarching goal of improving antibiotic access
and use therefore partly hinges on resolving the differ-
ences in demands between the regulatory authority and
community members on access to antibiotics. Resolving
the differences in demands will require a collaborative
approach among the Ghana Pharmacy Council, the LCS
Association of Ghana, the Ministry of Health, and other
stakeholders.
To resolve the differences in demands, LCS suggested
that, considering the unmet needs in Ghana’s healthcare
system, they should be trained and permitted to sell
some antibiotics, instead of being prevented completely
from the sales of antibiotics. They argue that the cre-
ation of a system which synthesises the demands of the
regulations with those of community members and
themselves will facilitate safe and appropriate antibiotic
access and use. Thus there is an opportunity for Ghana
to develop an innovative approach by restructuring its
regulatory framework and to train LCS, which could also
be a model for other countries struggling with inappro-
priate antibiotic sales. A systematic review of literature
could provide further evidence on the successes or fail-
ures of intervention studies which aimed to improve on
the dispensing practices of Over-the-Counter Medicine
Sellers in similar settings. However, as shown by studies
in Vietnam, training of drug sellers in private pharma-
cies can be effective in changing their knowledge and
dispensing practice [37, 38]. LCS in Ghana could there-
fore be trained to dispense WHO “key access antibiotics”
(first or second choice antibiotics). According to WHO,
these antibiotics should be widely available, affordable
and quality assured to improve antibiotic access and
health outcomes. Training LCS is tandem with WHO
2017 expert committees’ recommendation that “key
access antibiotics” should be a subject of targeted or spe-
cific stewardship programmes [39].
Leveraging the training of LCS is in line with the Phar-
macy Councils’ mission of collaborating with relevant
stakeholders (in this case the LCS) to enhance their
effectiveness and contribution to appropriate drug use in
Ghana [13]. This should also be seen against the back-
ground in which the regulators (i.e. the Pharmacy Coun-
cil) lack adequate resources to be able to monitor and
enforce the regulations on the sales of antibiotics. As a
result, suppliers hide the antibiotics that they hold in
stock when regulators go for inspection. The
task-shifting concept of training Licence Chemical sellers
to dispense some categories of antibiotics may be seen
as viable, because these same sellers in Ghana have pre-
viously been trained to test their clients with malaria
symptoms by using Malaria Rapid Diagnostic Test kits
before dispensing malaria medicines [40, 41].
Another possible point of entry for resolving the prob-
lem could come through the CHPS compounds in com-
munities, which could be equipped to dispense some
categories of antibiotics. CHPS is a national primary
health care programme designed to remove geographic
barriers to health care, and thereby to bridge the gaps
and inequality in healthcare provision. It is a structure
for the realization of the goals of primary health care
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and the program of work for the Health Sector Reforms
for Ghana Vision 2020 [42]. The call for Community
Health Officers in CHPS to be trained to dispense anti-
biotics reiterates the high emerging demand of the com-
munity for curative services provision in the CHPS
facilities, as specified in the revised CHPS policy
launched in 2016 [42]. As a study in Vietnam indicates,
equipping healthcare providers at community level could
improve their dispensing of antimicrobials [38]. This
suggestion could be facilitated by strengthening the clin-
ical orientation on the treatment of minor ailments such
as malaria, diarrhoea, acute respiratory infection given
to Community Health Officers post-graduation before
they are posted to the CHPS compounds.
The findings from this study reflect the principles of
the theory of structuration, which explores the relation-
ship between individuals and the social structures that
shape our social reality. Our findings indicate that while
there may be established social structures in the form of
traditions, institutions, moral codes and ways of doing
things, these structures can be changed when people ig-
nore them, replace them, or reproduce them differently.
In our context, regulations prevent LCS from legally sell-
ing antibiotics beyond cotrimoxazole, but this structure
has changed because LCS and community members
have found it to be inadequate to their respective needs,
and thus they have ignored and replaced it with a new
system whereby all types of antibiotic are sold by LCS.
Limitation and the need for further studies
This study has explored the perspective of suppliers and
community members on the differences between regula-
tory and community demands on the sale of antibiotics,
and how the differences in demand could be resolved to
improve on appropriate access, and use of antibiotics.
The views of policy makers are not represented in this
paper. Further studies will be required to explore the
perspective of policy makers for a holistic view on how
to meet the demand for antibiotics at the community
levels in Ghana while simultaneously ensuring that ac-
cess to and use of these drugs is optimized and safe.
Conclusion and recommendation
Access to antibiotics at the community level is influ-
enced by an interplay of structural and individual con-
textual factors. At the structural level, regulations are in
place to restrict important community-level suppliers of
medicines, such as LCS, from selling antibiotics (apart
from cotrimoxazole); however, at the community level,
antibiotics are sold because the community demands
them. The Pharmacy Council and other relevant stake-
holders are encouraged to consider training sellers at the
community level to dispense some essential antibiotics
in a manner that will optimise their safe use. Without
such a change in the regulations, LCS will continue to
hide and sell antibiotics, thereby promoting unsafe use
of antibiotics and, ultimately, resistance to the drugs.
Training LCS to dispense antibiotics would comprise a
collaborative and contextualized approach that would
synthesise the differences in demands of regulation and
the community concerning access to antibiotics. This
approach will also help the Pharmacy Council to achieve
its mission of securing the highest level of pharmaceut-
ical care in Ghana, while ensuring the availability of
competent pharmaceutical care providers who practice
within agreed standards and who are accessible to the
whole population. At the same time, the Ministry of
Health/Ghana Health Service may also want to consider
equipping CHPS compounds so that they are able to dis-
pense antibiotics, thereby facilitating appropriate access
to antibiotics.
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